These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Author: Georgotas A, Krakowski M, Gershon S.
    Journal: Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994.
    Abstract:
    The authors conducted a double-blind, placebo-controlled clinical trial of the selective 5-HT reuptake inhibitor zimelidine in the treatment of major depressive illness. Zimelidine had the same antidepressant efficacy as amitriptyline but significantly fewer side effects, especially anticholinergic effects.
    [Abstract] [Full Text] [Related] [New Search]